Tijmen J W T van der Wel
2PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Oct 01, 2024
Safety, Efficacy, and Biomarker Analysis of Crizotinib in MET-Mutated Non-Small Cell Lung Cancer-Results from the Drug Rediscovery Protocol.Karlijn Verkerk, Tijmen J W T van der Wel, Laurien J Zeverijn
|Aug 07, 2024
Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study.J W Tijmen van der Wel, Mirjam C Boelens, Merel Jebbink
Pageof 1
Frequent Collaborators
2 joint publications
Egbert F Smit
2 joint publications
Adrianus J de Langen
1 joint publications
Merel Jebbink
1 joint publications
Merel J A Luitse
1 joint publications
Annette Compter
1 joint publications
Nik Sol
1 joint publications
Kim Monkhorst
1 joint publications
Daan van den Broek
1 joint publications
Dieta Brandsma
1 joint publications
Karlijn Verkerk
